1.92
前日終値:
$1.95
開ける:
$1.92
24時間の取引高:
35,243
Relative Volume:
0.31
時価総額:
$1.99M
収益:
-
当期純損益:
$-6.85M
株価収益率:
-0.1244
EPS:
-15.4314
ネットキャッシュフロー:
$-6.23M
1週間 パフォーマンス:
+14.97%
1か月 パフォーマンス:
-4.00%
6か月 パフォーマンス:
-62.20%
1年 パフォーマンス:
-74.47%
Bluejay Diagnostics Inc Stock (BJDX) Company Profile
名前
Bluejay Diagnostics Inc
セクター
電話
(978) 631-0152
住所
360 MASSACHUSETTS AVENUE, SUITE 203, ACTON
Compare BJDX vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
BJDX
Bluejay Diagnostics Inc
|
1.92 | 2.02M | 0 | -6.85M | -6.23M | -15.43 |
|
ABT
Abbott Laboratories
|
87.41 | 152.88B | 45.13B | 6.28B | 7.38B | 3.5895 |
|
SYK
Stryker Corp
|
316.48 | 120.18B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
MDT
Medtronic Plc
|
78.60 | 100.34B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
57.78 | 84.95B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
85.78 | 47.91B | 6.30B | 1.07B | 1.09B | 1.8406 |
Bluejay Diagnostics Inc (BJDX) 最新ニュース
Bluejay Diagnostics (BJDX) Q4 2023 Earnings: Deeper-Than-Expected Losses as Development Spending Weighs on ResultsEarnings Stability Report - Newser
BJDX SEC FilingsBluejay Diagnostics Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Bluejay Diagnostics director Svetlana Dey buys $25,000 in common stock By Investing.com - Investing.com Nigeria
Bluejay Diagnostics CEO Indranil Dey purchases $25,000 stock By Investing.com - Investing.com Australia
Bluejay Diagnostics director Fred S Zeidman buys $25,000 in shares - Investing.com UK
Bluejay Diagnostics director Douglas Wurth buys $25,000 in stock - Investing.com
Bluejay Diagnostics director Fred S Zeidman buys $25,000 in shares By Investing.com - Investing.com Nigeria
Bluejay Diagnostics director Douglas Wurth buys $25,000 in stock By Investing.com - Investing.com Nigeria
Bluejay Diagnostics director Donald Chase buys $25,000 in common stock - Investing.com
Bluejay Diagnostics CEO Indranil Dey purchases $25,000 stock - Investing.com
Bluejay Diagnostics director Svetlana Dey buys $25,000 in common stock - Investing.com India
Director Wurth Douglas Clark boosts Bluejay Diagnostics (BJDX) stake in $2 private share purchase - Stock Titan
Bluejay Diagnostics (NASDAQ: BJDX) CEO adds 12,500 shares in private placement - Stock Titan
Bluejay Diagnostics (BJDX) director buys 12,500 shares at $2 - Stock Titan
Director Fred S. Zeidman buys 12,500 Bluejay Diagnostics (BJDX) shares at $2.00 - Stock Titan
Bluejay Diagnostics (BJDX) director buys 12,500 shares in placement - Stock Titan
[SCHEDULE 13G/A] Bluejay Diagnostics, Inc. Amended Passive Investment Disclosure - Stock Titan
BJDX Stock Chart | BLUEJAY DIAGNOSTICS INC (NASDAQ:BJDX) - ChartMill
TradingKey - TradingKey
Bluejay Diagnostics Provides First Quarter 2026 Corporate Update - The Manila Times
Bluejay Diagnostics : Quarterly Report for Quarter Ending March 31, 2026 (Form 10-Q) - marketscreener.com
Bluejay fixes sepsis test production issues, keeps 510(k) plan in view - Stock Titan
Bluejay Diagnostics (NASDAQ: BJDX) Q1 loss highlights urgent $20M funding need - Stock Titan
Bluejay Diagnostics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Bluejay Diagnostics (NASDAQ: BJDX) details Q1 2026 cash and sepsis test progress - Stock Titan
Bluejay Diagnostics advances clinical trials and manufacturing for sepsis test in Q1 2026. - Pluang
BJDX Stock Price, Quote & Chart | BLUEJAY DIAGNOSTICS INC (NASDAQ:BJDX) - ChartMill
Bluejay Diagnostics (NASDAQ: BJDX) seeks reverse split and major stock plan expansion - Stock Titan
BJDX Technical Analysis | Trend, Signals & Chart Patterns | BLUEJAY DIAGNOSTICS INC (NASDAQ:BJDX) - ChartMill
Bluejay Diag (BJDX) Innovation Pipeline | Q4 2023: Profit DisappointsForward EPS - Newser
BJDX Ownership | BLUEJAY DIAGNOSTICS INC (NASDAQ:BJDX) - ChartMill
Why Is Bluejay Diagnostics, Inc. (BJDX) Stock Down Today? - Meyka
Board seeks flexible reverse split, plan increase at Bluejay Diagnostics (NASDAQ: BJDX) - Stock Titan
Is Bluejay Diag (BJDX) stock risky (Slight Dip) 2026-04-20Social Flow Trades - Cổng thông tin điện tử Tỉnh Sơn La
bjdx stock: Bluejay Diagnostics Overview - Bitget
Aug Summary: How is Bluejay Diagnostics Inc managing supply chain issues2026 Technical Patterns & Growth Focused Entry Reports - baoquankhu1.vn
Macro Review: Is Bluejay Diagnostics Inc gaining market share2026 Trading Recap & Free Low Drawdown Momentum Trade Ideas - baoquankhu1.vn
Bluejay Diagnostics Nears Completion of SYMON-II Clinical Trial with 624 Patient Enrollments for Symphony IL-6 Sepsis Test - Minichart
Bluejay Nears Completion of Pivotal SYMON-II Sepsis Trial - TipRanks
SYMON-II sepsis trial nears full enrollment at Bluejay (NASDAQ: BJDX) - Stock Titan
Bluejay Diagnostics, Inc. Announces Completion of 624 Patient Enrollments in SYMON-II Pivotal Clinical Trial - Bitget
Bluejay Diagnostics, Inc. Announces Completion Of 624 Patient Enrollments In Symon-Ii Pivotal Clinical Trial - TradingView — Track All Markets
Bluejay Diagnostics Achieves Milestone with 624 Patients Enrolled in Pivotal SYMON-II Trial for IL-6 Testing in Sepsis Management - Quiver Quantitative
BJDX Technical Analysis & Stock Price Forecast - Intellectia AI
Are insiders buying or selling Bluejay Diag (BJDX) Stock | Price at $1.95, Up 3.17%Investment Community Signals - Newser
Volume Recap: Why is Bluejay Diagnostics Inc stock going down2026 Pullback Review & Weekly Top Performers Watchlists - baoquankhu1.vn
Analyst Upgrade: How is Bluejay Diagnostics Inc managing supply chain issuesNew Guidance & Real-Time Buy Zone Alerts - baoquankhu1.vn
BJDX PE Ratio & Valuation, Is BJDX Overvalued - Intellectia AI
Bluejay Diagnostics, Inc. Enters Securities Purchase Agreement for $25,000 Private Placement of Common Stock - Minichart
Bluejay Diagnostics Announces Insider-Funded Private Stock Placement - TipRanks
Bluejay Diagnostics completes $125,000 private placement with board members - Investing.com
Bluejay Diagnostics Inc (BJDX) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):